T. Danny Phillips

CIK: 0001239690

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAI

Caris Life Sciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

CAI
Caris Life Sciences, Inc.
Aug 14, 2026
Award(A)
Direct
13.2K shares-
CAI
Caris Life Sciences, Inc.
Feb 26, 2026
Award(A)
Direct
3.7K shares at avg. $20.06$75K
CAI
Caris Life Sciences, Inc.
Sep 11, 2025
Exercise(M)
Direct
100K shares at avg. $2.44$244K

		Type	Shares	Price		Ownership
Aug 14, 2026	CAI Caris Life Sciences, Inc.	Award(A)	13,192	-	$0	Direct
Feb 26, 2026	CAI Caris Life Sciences, Inc.	Award(A)	3,739	$20.06	$75,004	Direct
Sep 11, 2025	CAI Caris Life Sciences, Inc.	Exercise(M)	100,000	$2.44	$244,000	Direct

1-3 of 3 transactions

About PHILLIPS T DANNY

PHILLIPS T DANNY (SEC CIK 0001239690) files insider reports with the SEC as Director of Caris Life Sciences, Inc. (CAI).

Signal8 holds 4 ownership filings by PHILLIPS T DANNY (1 Form 3, 3 Form 4), filed between Jun 17, 2025 and Aug 14, 2026. Those filings report 3 transactions, from Sep 11, 2025 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on PHILLIPS T DANNY's filings is in IRVING, TX.

Recent filings by PHILLIPS T DANNY

Aug 14, 2026: Grant or award of CAI shares (Form 4, code A).
Feb 26, 2026: Grant or award of CAI shares (Form 4, code A).
Sep 11, 2025: Option exercise of CAI shares (Form 4, code M).

Other insiders filing for Caris Life Sciences, Inc. (CAI)

How to read Form 4 transaction codes